The Medical News

1. European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease

   Neuraxpharm Group and Minoryx Therapeutics, today announce that the European Commission (EC) has granted marketing authorization under exceptional circumstances for NEZGLYAL® (leriglitazone), an orally bioavailable, brain penetrating, selective PPAR gamma agonist, as a treatment for male cALD patients, aged 2-12 years with Gadolinium (Gd)-negative brain lesions.

2. Recruitment begins for 600 future medical researchers

   Through a £90 million Medical Research Council (MRC) investment, researchers will undertake PhDs and get experience in academia, healthcare and industry.

3. Virtual reality and music may help lower blood pressure during emergencies

   A virtual reality landscape of a flowing river and trees, accompanied by classical music, can help to reduce patients' blood pressure significantly within 15 minutes of their being seen in an emergency department.

4. Drone-delivered AEDs could reduce defibrillation delays after cardiac arrest

   Drones could be used to deliver automated external defibrillators (AEDs) to where a person is suffering an out-of-hospital cardiac arrest, according to a study presented at the European Emergency Medicine Congress today (Saturday).

5. MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026

   Experts from The University of Texas MD Anderson Cancer Center will present nearly 70 abstracts at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting.

6. UCLA researchers present new radiation advances at ASTRO 2026

   Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial findings at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on new treatment approaches for prostate, bile duct and head and neck cancers, personalized radiation therapy based on genetic risk, and advances in targeted radiation and radioligand therapy designed to improve cancer control while limiting treatment side effects.

7. AI-based model predicts glioblastoma recurrence to guide targeted treatment

   A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

8. AI-generated video summaries can reshape people's memories of events

   AI-generated summaries are becoming increasingly prevalent - from news article previews to workplace meeting transcriptions to high-stakes settings like police body camera footage - despite studies showing that AI can generate misleading or inaccurate information.